Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000560462 | SCV000648082 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2023-12-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000567536 | SCV000672140 | likely benign | Hereditary cancer-predisposing syndrome | 2015-11-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000567536 | SCV002532937 | likely benign | Hereditary cancer-predisposing syndrome | 2021-09-25 | criteria provided, single submitter | curation | |
Ce |
RCV003886410 | SCV004703129 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | SMARCA4: BP4, BP7 |